Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Earnings symbols : JNJ save search
OmniAb Reports Fourth Quarter and Full Year 2023 Financial Results and Business Highlights
Published: 2024-03-20 (Crawled : 00:00) - biospace.com/
OABI | News | $4.69 0.43% 0.43% 300K
|
|
| O: -0.76%
H: 4.02%
C: 3.63%
JNJ | News | $149.12 0.82% 0.0% 9.3M
|
Health Technology
|
| O: -0.65%
H: 0.0%
C: 0.0%
business year financial results
Protagonist Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
Published: 2024-02-27 (Crawled : 00:00) - biospace.com/
JNJ | News | $149.12 0.82% 0.0% 9.3M
|
Health Technology
|
| O: -1.07%
H: 0.0%
C: 0.0%
PTGX S | $26.6 3.87% 3.72% 300K
|
Health Technology
|
| O: 0.3%
H: 1.25%
C: -0.1%
year update financial results
Xencor Reports Fourth Quarter and Full Year 2023 Financial Results
Published: 2024-02-27 (Crawled : 00:00) - biospace.com/
JNJ | News | $149.12 0.82% 0.0% 9.3M
|
Health Technology
|
| O: -1.07%
H: 0.0%
C: 0.0%
XNCR | $18.19 -1.03% -1.04% 490K
|
Health Technology
|
| O: 1.2%
H: 2.52%
C: 1.3%
year financial results
LivaNova Reports Fourth-Quarter and Full-Year 2023 Results
Published: 2024-02-21 (Crawled : 12:00) - biospace.com/
JNJ | News | $149.12 0.82% 0.0% 9.3M
|
Health Technology
|
| O: 0.8%
H: 0.0%
C: 0.0%
LIVN | $54.005 3.2% 3.1% 710K
|
Health Technology
|
| O: 5.51%
H: 4.14%
C: 2.38%
results
Alkermes plc Reports Financial Results for the Fourth Quarter and Year Ended Dec. 31, 2023 and Provides Financial Expectations for 2024
Published: 2024-02-15 (Crawled : 13:00) - biospace.com/
MURA | $3.56 -0.28% -0.28% 230K
|
|
| O: 2.78%
H: 8.11%
C: 3.53%
JNJ | News | $149.12 0.82% 0.0% 9.3M
|
Health Technology
|
| O: -0.19%
H: 1.6%
C: 1.24%
ALKS | $24.06 0.88% 0.87% 1.7M
|
Health Technology
|
| O: 2.72%
H: 13.77%
C: 13.25%
year financial results
COVID-19 Cliff and Skyrocketing GLP-1 Drug Sales Highlight Q4 2023 Earnings
Published: 2024-02-09 (Crawled : 17:00) - biospace.com/
JNJ | News | $149.12 0.82% 0.0% 9.3M
|
Health Technology
|
| O: -0.68%
H: 0.0%
C: 0.0%
SNY | News | $47.125 1.78% 1.75% 2.1M
|
Health Technology
|
| O: 1.11%
H: 0.0%
C: 0.0%
covid-19 sales drug
Kenvue Reports Full Year and Fourth Quarter 2023 Results
Published: 2024-02-08 (Crawled : 12:30) - biospace.com/
KVUE 4 | $19.58 0.0% 17M
|
n/a
|
| O: -3.27%
H: 0.98%
C: -2.62%
JNJ | News | $149.12 0.82% 0.0% 9.3M
|
Health Technology
|
| O: -0.63%
H: 0.0%
C: 0.0%
year results
J&J Beats Q4 Expectations, Reports $21.4B in Revenue as Faces Patent Cliff
Published: 2024-01-23 (Crawled : 17:00) - biospace.com/
JNJ | News | $149.12 0.82% 0.0% 9.3M
|
Health Technology
|
| O: -1.11%
H: 0.0%
C: 0.0%
patent revenue
Adimab Provides Year-End Update on 2023 Partnership Activities
Published: 2024-01-08 (Crawled : 16:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: 2.07%
H: 0.48%
C: 0.48%
JNJ | News | $149.12 0.82% 0.0% 9.3M
|
Health Technology
|
| O: 0.47%
H: 0.0%
C: 0.0%
SNY | News | $47.125 1.78% 1.75% 2.1M
|
Health Technology
|
| O: 1.16%
H: 0.0%
C: 0.0%
partnership update
Arrowhead Pharmaceuticals Reports Fiscal 2023 Year End Results
Published: 2023-11-29 (Crawled : 00:00) - biospace.com/
JNJ | News | $149.12 0.82% 0.0% 9.3M
|
Health Technology
|
| O: -0.04%
H: 0.0%
C: 0.0%
ARWR | $23.94 7.21% 6.73% 1.1M
|
Health Technology
|
| O: 1.94%
H: 0.0%
C: -1.7%
year pharmaceuticals results
Johnson & Johnson to Host Enterprise Business Review
Published: 2023-11-16 (Crawled : 17:00) - biospace.com/
JNJ | News | $149.12 0.82% 0.0% 9.3M
|
Health Technology
|
| O: 1.4%
H: 0.0%
C: 0.0%
business review
Biopharma Industry Continues to Bet Big on Antibody-Drug Conjugates
Published: 2023-10-20 (Crawled : 21:00) - biospace.com/
JNJ | News | $149.12 0.82% 0.0% 9.3M
|
Health Technology
|
| O: 0.47%
H: 0.0%
C: 0.0%
biopharma
J&J Sees Nearly 7% Growth in Q3, Increases Full-Year Guidance
Published: 2023-10-17 (Crawled : 15:30) - biospace.com/
JNJ | News | $149.12 0.82% 0.0% 9.3M
|
Health Technology
|
| O: -0.61%
H: 0.0%
C: 0.0%
growth
Week in Review: FTC Gets Tougher on Mergers, AAIC Data Dump, and Q2 Beat for ...
Published: 2023-07-21 (Crawled : 22:00) - biospace.com/
JNJ | News | $149.12 0.82% 0.0% 9.3M
|
Health Technology
|
| O: -0.12%
H: 1.57%
C: 1.2%
aaic week
J&J Exceeds Q2 Expectations, Oncology and Immunology Top Pharma Drivers
Published: 2023-07-20 (Crawled : 15:20) - biospace.com/
JNJ | News | $149.12 0.82% 0.0% 9.3M
|
Health Technology
|
| O: 2.02%
H: 4.45%
C: 3.98%
pharma immunology
Bristol Myers Squibb Reports First Quarter Financial Results for 2023
Published: 2023-04-27 (Crawled : 12:20) - biospace.com/
TSVT | $4.67 3.32% 3.21% 410K
|
|
| O: 0.71%
H: 8.58%
C: 5.64%
XYF | News | $3.875 2.51% 0.65% 6K
|
Finance
|
| O: -3.13%
H: 3.23%
C: 1.94%
JNJ | News | $149.12 0.82% 0.0% 9.3M
|
Health Technology
|
| O: 0.17%
H: 0.31%
C: 0.06%
BMY | $49.14 0.43% 0.0% 7.9M
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: -0.6%
financial results
Milestone Pharmaceuticals Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Clinical and Corporate Update
Published: 2023-03-29 (Crawled : 14:00) - biospace.com/
JNJ | News | $149.12 0.82% 0.0% 9.3M
|
Health Technology
|
| O: 0.28%
H: 0.75%
C: 0.7%
SPPI | $1.03 -0.97% 0
|
Health Technology
|
| O: 3.0%
H: 4.33%
C: 2.88%
MIST | $1.69 3.05% 2.96% 35K
|
Health Technology
|
| O: 2.76%
H: 0.24%
C: -4.88%
MRNS | $1.48 7.25% 6.76% 3.2M
|
Health Technology
|
| O: 1.28%
H: 12.5%
C: 10.28%
AGRX | $0.38 0.0% 48K
|
Health Technology
|
| O: 6.92%
H: 0.04%
C: -1.9%
year update pharmaceuticals financial results milestone
Sonnet BioTherapeutics Provides Fiscal Year 2023 First Quarter Business and Earnings Update
Published: 2023-02-13 (Crawled : 15:20) - biospace.com/
JNJ | News | $149.12 0.82% 0.0% 9.3M
|
Health Technology
|
| O: -0.51%
H: 0.92%
C: 0.88%
SONN | $1.77 -2.75% -2.82% 18K
|
Health Technology
|
| O: -3.74%
H: 4.3%
C: 1.08%
year update
Encision Reports Third Quarter Fiscal Year 2023 Results
Published: 2023-02-07 (Crawled : 11:00) - biospace.com/
JNJ | News | $149.12 0.82% 0.0% 9.3M
|
Health Technology
|
| O: -1.08%
H: 1.41%
C: 1.11%
year results
Johnson & Johnson Reports Q4 and Full-Year 2022 Results
Published: 2023-01-24 (Crawled : 13:00) - biospace.com/
JNJ | News | $149.12 0.82% 0.0% 9.3M
|
Health Technology
|
| O: 3.97%
H: 0.0%
C: -3.82%
results
Gainers vs Losers
| 75% | 25% |
Top 10 Gainers
MTTR | News M | $4.78 174.71% 63.6% 72M
|
AGBA | $2.565 105.2% 51.27% 200M
|
Finance
MLEC | $2.44 74.29% 42.62% 78M
|
n/a
EDBL | News | $6.28 67.02% 40.13% 16M
|
ATGL | $2.91 48.81% 32.8% 180K
|
ZAPP | $0.2175 47.16% 32.05% 16M
|
n/a
ONFO | $0.6075 38.38% 27.74% 7.3M
|
n/a
VIVK | $1.48 38.32% 27.7% 530K
|
Professional, Scientific, and T...
MNTS | $0.5 35.69% 26.3% 4.8M
|
SDIG A | $3.635 35.13% 26.0% 1M
|
Your saved searches
Save your searches and get alerts when important news are released.